Sleep Number Financial Statements (SNBR)
|
|
|
|
Report date
|
|
|
01.03.2022 |
24.02.2023 |
23.02.2024 |
07.03.2025 |
12.03.2026 |
|
12.03.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
2 185 |
2 114 |
1 887 |
1 682 |
1 411 |
|
1 411 |
|
Operating Income, bln rub |
|
|
193.5 |
67.9 |
22.9 |
22.9 |
4.11 |
|
-43.4 |
|
EBITDA, bln rub |
? |
|
253.9 |
135.3 |
95.3 |
89.2 |
57.3 |
|
57.3 |
|
Net profit, bln rub |
? |
|
153.7 |
36.6 |
-15.3 |
-20.3 |
-132.0 |
|
-132.0 |
|
|
OCF, bln rub |
? |
|
300.0 |
36.1 |
-9.03 |
27.1 |
-3.28 |
|
-2.97 |
|
CAPEX, bln rub |
? |
|
66.9 |
69.5 |
57.1 |
23.5 |
14.4 |
|
17.7 |
|
FCF, bln rub |
? |
|
233.1 |
-33.3 |
-66.1 |
3.64 |
-17.7 |
|
-20.7 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
|
|
|
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
1 125 |
1 134 |
1 066 |
979.9 |
828.8 |
|
876.3 |
|
Cost of production, bln rub |
|
|
866.1 |
912.0 |
799.0 |
679.5 |
578.5 |
|
578.5 |
|
R&D, bln rub |
|
|
58.5 |
61.5 |
55.8 |
45.3 |
0.034 |
|
55.3 |
|
Interest expenses, bln rub |
|
|
6.25 |
19.0 |
42.7 |
48.4 |
49.4 |
|
49.4 |
|
|
Assets, bln rub |
|
|
919.5 |
953.9 |
950.9 |
860.8 |
680.1 |
|
680.1 |
|
Net Assets, bln rub |
? |
|
-425.0 |
-438.2 |
-441.9 |
-451.6 |
-578.5 |
|
-578.5 |
|
Debt, bln rub |
|
|
791.1 |
896.0 |
972.7 |
936.1 |
942.5 |
|
942.5 |
|
Cash, bln rub |
|
|
2.39 |
1.79 |
2.54 |
1.95 |
1.69 |
|
1.69 |
|
Net debt, bln rub |
|
|
788.7 |
894.2 |
970.1 |
934.2 |
940.8 |
|
940.8 |
|
|
Ordinary share price, rub |
|
|
76.6 |
26.0 |
|
|
|
|
2.85 |
|
Number of ordinary shares, mln |
|
|
24.0 |
22.4 |
22.4 |
22.6 |
22.9 |
|
22.9 |
|
|
Market cap, bln rub |
|
|
1 841 |
582 |
0 |
0 |
0 |
|
65 |
|
EV, bln rub |
? |
|
2 630 |
1 476 |
970 |
934 |
941 |
|
1 006 |
|
Book value, bln rub |
|
|
-495 |
-506 |
-509 |
-518 |
-645 |
|
-645 |
|
|
EPS, rub |
? |
|
6.40 |
1.63 |
-0.68 |
-0.90 |
-5.76 |
|
-5.76 |
|
FCF/share, rub |
|
|
9.70 |
-1.49 |
-2.95 |
0.16 |
-0.77 |
|
-0.90 |
|
BV/share, rub |
|
|
-20.6 |
-22.6 |
-22.7 |
-22.9 |
-28.2 |
|
-28.2 |
|
|
EBITDA margin, % |
? |
|
11.6% |
6.40% |
5.05% |
5.30% |
4.06% |
|
4.06% |
|
Net margin, % |
? |
|
7.04% |
1.73% |
-0.81% |
-1.21% |
-9.35% |
|
-9.35% |
|
FCF yield, % |
? |
|
12.7% |
-5.73% |
|
|
|
|
-31.6% |
|
ROE, % |
? |
|
-36.2% |
-8.36% |
3.46% |
4.50% |
22.8% |
|
22.8% |
|
ROA, % |
? |
|
16.7% |
3.84% |
-1.61% |
-2.36% |
-19.4% |
|
-19.4% |
|
|
P/E |
? |
|
12.0 |
15.9 |
0.00 |
0.00 |
0.00 |
|
-0.49 |
|
P/FCF |
|
|
7.90 |
-17.5 |
0.00 |
0.00 |
0.00 |
|
-3.16 |
|
P/S |
? |
|
0.84 |
0.28 |
0.00 |
0.00 |
0.00 |
|
0.05 |
|
P/BV |
? |
|
-3.72 |
-1.15 |
0.00 |
0.00 |
0.00 |
|
-0.10 |
|
EV/EBITDA |
? |
|
10.4 |
10.9 |
10.2 |
10.5 |
16.4 |
|
17.6 |
|
Debt/EBITDA |
|
|
3.11 |
6.61 |
10.2 |
10.5 |
16.4 |
|
16.4 |
|
|
R&D/CAPEX, % |
|
|
87.5% |
88.6% |
97.8% |
192.5% |
0.24% |
|
312.5% |
|
|
CAPEX/Revenue, % |
|
|
3.06% |
3.28% |
3.02% |
1.40% |
1.02% |
|
1.25% |
|
| Sleep Number shareholders |
